Carbapenem-Resistant KPC- And TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018

31Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In July 2018, a Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli ST131 was isolated from a patient admitted to the Vascular Surgery Unit of the main hospital of Molise region, Central Italy. Sequencing and alignment with the available sequences revealed that the isolate harbored the KPC-2 variant and TEM-1 beta-lactamase. This observation raises great concerns about the spread of carbapenem resistance in national and local settings with high endemicity level of KPC in K. pneumoniae, and underlines the importance of strengthening a proactive surveillance.

Cite

CITATION STYLE

APA

Ripabelli, G., Sammarco, M. L., Scutellà, M., Felice, V., & Tamburro, M. (2020). Carbapenem-Resistant KPC- And TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018. Microbial Drug Resistance, 26(1), 38–45. https://doi.org/10.1089/mdr.2019.0085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free